Ferozsons Laboratories Limited (PSX:FEROZ)

Ferozsons Laboratories Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	642.11	692.53	551.06	569.05	415.83
Trading Asset Securities	410.96	1,661	496.5	544.97	2,036
Cash & Short-Term Investments	1,053	2,354	1,048	1,114	2,452
Cash Growth	-55.26%	124.67%	-5.96%	-54.57%	-11.51%
Accounts Receivable	2,589	2,301	2,417	1,123	1,140
Other Receivables	127.41	285.31	283.81	259.9	432.11
Receivables	2,717	2,587	2,700	1,383	1,572
Inventory	9,102	6,806	4,978	5,196	3,260
Prepaid Expenses	27.8	28.72	11.84	7.05	1.15
Other Current Assets	1,049	1,123	1,046	833	468.26
Total Current Assets	13,949	12,898	9,783	8,533	7,754
Property, Plant & Equipment	11,705	11,557	11,828	7,975	6,113
Other Intangible Assets	14.81	27.63	41.04	1.55	1
Other Long-Term Assets	253.48	122.21	96.98	93.92	93.92
Total Assets	25,922	24,605	21,750	16,603	13,962

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	1,713	1,931	1,125	2,716	1,657
Accrued Expenses	1,650	1,017	897.6	539.82	611.89
Short-Term Debt	2,585	2,248	2,743	1,261	492.52
Current Portion of Long-Term Debt	417.69	395.74	333.07	379.88	141.69
Current Unearned Revenue	366.73	469.33	471.27	251.96	200.95
Other Current Liabilities	709.13	590.94	514.79	343.17	282.76
Total Current Liabilities	7,442	6,652	6,085	5,491	3,387
Long-Term Debt	1,249	1,648	1,844	1,841	1,537
Long-Term Unearned Revenue	237.65	351.55	476.91	531.88	331.33
Long-Term Deferred Tax Liabilities	1,407	1,487	1,524	375.36	408.64
Total Liabilities	10,336	10,138	9,929	8,240	5,664

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	434.69	434.69	434.69	434.69	362.24
Retained Earnings	9,400	8,396	7,040	6,290	6,100
Comprehensive Income & Other	3,405	3,544	3,754	1,193	1,305
Total Common Equity	13,239	12,375	11,228	7,918	7,768
Minority Interest	2,347	2,091	591.88	445.45	530.68
Shareholders' Equity	15,586	14,467	11,820	8,364	8,298
Total Liabilities & Equity	25,922	24,605	21,750	16,603	13,962

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	4,252	4,292	4,920	3,482	2,171
Net Cash (Debt)	-3,199	-1,938	-3,872	-2,368	280.9
Net Cash Growth	-	-	-	-	-82.79%
Net Cash Per Share	-73.59	-44.59	-89.08	-54.47	6.46
Filing Date Shares Outstanding	43.47	43.47	43.47	43.47	43.47
Total Common Shares Outstanding	43.47	43.47	43.47	43.47	43.47
Working Capital	6,507	6,246	3,698	3,042	4,367
Book Value Per Share	304.56	284.69	258.31	182.16	178.70
Tangible Book Value	13,224	12,348	11,187	7,917	7,767
Tangible Book Value Per Share	304.22	284.05	257.36	182.12	178.67
Land	1,813	1,813	1,691	849.15	849.15
Buildings	2,678	2,671	2,013	1,117	1,048
Machinery	8,923	8,413	5,077	3,363	2,980
Construction In Progress	705.28	168.56	3,708	4,160	2,337

Data Source: S&P Global Market Intelligence Last updated: Oct 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error